Learn, Analyse & Invest
only with
only with
+91
Download Orca
Tejnaksh Healthcare Ltd.
Tejnaksh Healthcare
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹32.50 Cr.
| EX-Date | Purpose |
|---|---|
| 29 04 2021 | Inter alia, to transact the business as given below: 1. To shift the registered office of the Company from Lion Tarachand Bapa Hospital, Lion Tarachand Bapa Hospital Marg, Sion -West, Mumbai - 400022. 2. Any other matter with the permission of chair. |
| 29 06 2021 | Quarterly Results & Audited Results Inter alia, 2. To take note of resignation of Mr. Pratap Tarachand Patil (DIN: 08765839) as an Independent Director of the Company. |
| 14 08 2021 | Quarterly Results & Inter alia, 2. To consider and appoint Mr. Suhas Vasantrao Thorat (DIN: 09241231) as an Additional Director of the Company 3. Any other matter with the permission of the Chair. |
| 12 11 2021 | Quarterly Results |
| 12 02 2022 | Quarterly Results |
| 17 05 2022 | Audited Results |
| 11 08 2022 | Quarterly Results |
| 07 11 2022 | Quarterly Results |
| 11 02 2023 | Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2023 ,inter alia, to consider andapprove a. Un-audited financial result (Standalone and Consolidated) for quarter ended on December 31, 2022; b. Sub-division of (Change in face value) of equityshare of the Company; c. The Appointment of Mr. Nandish Dave, Company Secretary as a Secretarial Auditor of the Company for FY 2022-23; d. Any other matterwith the permission of the Chair. |
| 20 05 2023 | Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday, May 20, 2023 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 to transact the business as given below: 1. To Consider and approve Audited Financial Results (Standalone & Consolidated) for the Quarter and year ended March 31, 2023; 2. To consider sub-division (Change in Face Value) of equity share of the Company. 3. To consider the agenda with respect to Change of Registrar and Share Transfer Agent of the Company. 4. To Consider and Approve the Appointment of Internal Auditor. |
| 12 08 2023 | Quarterly Results |
| 11 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 23 01 2025 | Rights Issue & Increase in Authorised Capital & Right Issue of Equity Shares |
| 11 02 2025 | Quarterly Results |
| 12 04 2025 | Rights Issue & Inter alia, to discuss the following agenda, including but not limited to: 1. To consider, take on record and approve the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company. 2. To Consider Change in Registered office of the company within the local limits of same Town & City. 3. Any other matter with permission of Chairman of the meeting. |
| 29 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 08 11 2025 | Quarterly Results |
| 07 02 2026 | Quarterly Results |
News
